These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32298386)

  • 1. Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
    Zhang H; Luo M; Liang X; Wang D; Gu X; Duan C; Gu H; Chen G; Zhao X; Zhao Z; Liu C
    PLoS One; 2020; 15(4):e0232166. PubMed ID: 32298386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis.
    D'Haene N; Sauvage S; Maris C; Adanja I; Mercier ML; Decaestecker C; Baum L; Salmon I
    PLoS One; 2023; 18(12):e0295736. PubMed ID: 38060508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    Vitali F; Cohen LD; Demartini A; Amato A; Eterno V; Zambelli A; Bellazzi R
    PLoS One; 2017; 12(1):e0170363. PubMed ID: 28076436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(5):e0216968. PubMed ID: 31071170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.
    Dotan I; Roche PJ; Tamilia M; Paliouras M; Mitmaker EJ; Trifiro MA
    PLoS One; 2016; 11(6):e0158022. PubMed ID: 27309538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    Cheng W; Shen X; Xing M
    PLoS One; 2019; 14(11):e0225986. PubMed ID: 31770417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: breast cancer screening in Saudi Arabia: free but almost no takers.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0124850. PubMed ID: 25853811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    Lyng FM; Traynor D; Nguyen TNQ; Meade AD; Rakib F; Al-Saady R; Goormaghtigh E; Al-Saad K; Ali MH
    PLoS One; 2019; 14(4):e0216311. PubMed ID: 31022278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(9):e0162936. PubMed ID: 27607428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
    PLoS One; 2017; 12(6):e0179098. PubMed ID: 28570622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.
    Fukushima S; Endo M; Matsumoto Y; Fukushi JI; Matsunobu T; Kawaguchi KI; Setsu N; IIda K; Yokoyama N; Nakagawa M; Yahiro K; Oda Y; Iwamoto Y; Nakashima Y
    PLoS One; 2018; 13(3):e0194508. PubMed ID: 29543881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    Raghuram GV; Pal K; Sriram G; Khan A; Joshi R; Jadhav V; Shinde S; Shaikh A; Rane B; Kangne H; Mittra I
    PLoS One; 2024; 19(3):e0301650. PubMed ID: 38547094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    Bromberg SE; Moraes PRAF; Ades F
    PLoS One; 2018; 13(3):e0195130. PubMed ID: 29579107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLOS ONE Staff
    PLoS One; 2017; 12(3):e0174493. PubMed ID: 28301577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    Haraldsdottir A; Torfadottir JE; Valdimarsdottir UA; Adami HO; Aspelund T; Tryggvadottir L; Thordardottir M; Birgisdottir BE; Harris TB; Launer LJ; Gudnason V; Steingrimsdottir L
    PLoS One; 2018; 13(10):e0206026. PubMed ID: 30321233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2018; 13(1):e0191579. PubMed ID: 29342211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(8):e0183201. PubMed ID: 28793330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    Wittkowski KM; Dadurian C; Seybold MP; Kim HS; Hoshino A; Lyden D
    PLoS One; 2019; 14(3):e0214826. PubMed ID: 30921433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.